Surmodics | SRDX - Current Assets


Surmodics reported $75.99M in Current Assets for its fiscal quarter ending in June of 2025.





Current Assets Change Date
Abbott USD 25.51B 488M Mar/2026
Align Technology USD 2.66B 38.87M Mar/2026
Anika Therapeutics USD 93.56M 9.8M Mar/2026
Arrowhead Research USD 1.84B 665.36M Mar/2026
Artivion USD 357.52M 566K Mar/2026
Baxter International USD 6.85B 25M Mar/2026
Boston Scientific USD 8.68B 110M Mar/2026
EDAP TMS EUR 44.35M 7.13M Sep/2025
Edwards Lifesciences USD 6.23B 510.2M Mar/2026
Haemonetics USD 943.67M 43.99M Dec/2025
Heron Therapeutics USD 228.98M 9.08M Mar/2026
J&J USD 59.17B 3.55B Mar/2026
Merit Medical Systems USD 1.1B 61.62M Mar/2026
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Nektar Therapeutics USD 266.27M 15.09M Dec/2025
Option Care Health USD 1.2B 69.86M Mar/2026
Stryker USD 13.34B 1.42B Mar/2026
Surmodics USD 75.99M 5.31M Jun/2025
Trinity Biotech USD 35.52M 2.52M Sep/2025